Laman Utama207940 • KRX
add
Samsung Biologics Co Ltd
Tutup sebelumnya
₩1,000,000.00
Julat hari
₩1,005,000.00 - ₩1,044,000.00
Julat tahun
₩721,000.00 - ₩1,113,000.00
Permodalan pasaran
72.03T KRW
Bilangan Purata
71.47K
Nisbah P/E
68.43
Hasil dividen
-
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (KRW) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 1.19T | 14.81% |
Perbelanjaan pengendalian | 202.29B | 11.50% |
Pendapatan bersih | 264.47B | 10.03% |
Margin untung bersih | 22.28 | -4.17% |
Pendapatan bagi setiap syer | 3.72K | 10.07% |
EBITDA | 495.40B | 8.39% |
Kadar cukai berkesan | 9.12% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (KRW) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 988.11B | -45.63% |
Jumlah aset | 16.03T | 0.87% |
Jumlah liabiliti | 5.43T | -14.30% |
Jumlah ekuiti | 10.59T | — |
Syer tertunggak | 71.17J | — |
Harga kepada buku | 6.72 | — |
Pulangan pada aset | 5.23% | — |
Pulangan pada modal | 7.18% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (KRW) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 264.47B | 10.03% |
Tunai daripada operasi | 740.39B | 154.07% |
Tunai daripada pelaburan | -437.12B | -17.41% |
Tunai daripada pembiayaan | -713.37B | -297.72% |
Perubahan bersih dalam tunai | -433.28B | -69.49% |
Aliran tunai bebas | -12.12B | -237.42% |
Perihal
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
CEO
Diasaskan
2011
Tapak web
Pekerja
4,744
